|
CDKN3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.35897976100341E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.06849995518132E-09 |
| Normal-vs-Stage2 |
1.184370E-04 |
| Normal-vs-Stage3 |
7.359400E-04 |
| Normal-vs-Stage4 |
6.26019999999672E-05 |
| Stage1-vs-Stage2 |
6.342400E-01 |
| Stage1-vs-Stage3 |
1.512030E-01 |
| Stage1-vs-Stage4 |
8.636500E-03 |
| Stage2-vs-Stage3 |
2.890800E-01 |
| Stage2-vs-Stage4 |
2.096500E-02 |
| Stage3-vs-Stage4 |
1.840630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.48672218769752E-12 |
| Normal-vs-AfricanAmerican |
1.641580E-04 |
| Normal-vs-Asian |
5.89739999999894E-05 |
| Caucasian-vs-AfricanAmerican |
4.737800E-03 |
| Caucasian-vs-Asian |
7.112600E-01 |
| AfricanAmerican-vs-Asian |
6.931700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.7150998357165E-10 |
| Normal-vs-Female |
2.5924995483706E-10 |
| Male-vs-Female |
4.531900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.566930E-04 |
| Normal-vs-Age(41-60Yrs) |
3.31289999999651E-06 |
| Normal-vs-Age(61-80Yrs) |
7.24253990114221E-12 |
| Normal-vs-Age(81-100Yrs) |
4.764200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.956400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.621400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.513370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.015600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.792000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.778800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.453650E-02 |
| Normal-vs-Grade 2 |
3.3259994758339E-10 |
| Normal-vs-Grade 3 |
2.15329999997405E-06 |
| Normal-vs-Grade 4 |
1.244500E-04 |
| Grade 1-vs-Grade 2 |
1.234500E-02 |
| Grade 1-vs-Grade 3 |
4.119600E-03 |
| Grade 1-vs-Grade 4 |
1.604170E-03 |
| Grade 2-vs-Grade 3 |
1.251600E-01 |
| Grade 2-vs-Grade 4 |
1.070210E-02 |
| Grade 3-vs-Grade 4 |
7.205600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.50369999785127E-08 |
| Normal-vs-ccB subtype |
3.41240000034659E-07 |
| ccA subtype-vs-ccB subtype |
1.275210E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.51239999991138E-07 |
| Normal-vs-N1 |
2.619400E-04 |
| N0-vs-N1 |
3.198200E-01 |
|
|
